NVDA

185.56

+0.26%↑

AVGO.US

356.61

+1.8%↑

ORCL

202.03

-1.54%↓

MU

341.18

-1.13%↓

CSCO

74.74

+1.45%↑

NVDA

185.56

+0.26%↑

AVGO.US

356.61

+1.8%↑

ORCL

202.03

-1.54%↓

MU

341.18

-1.13%↓

CSCO

74.74

+1.45%↑

NVDA

185.56

+0.26%↑

AVGO.US

356.61

+1.8%↑

ORCL

202.03

-1.54%↓

MU

341.18

-1.13%↓

CSCO

74.74

+1.45%↑

NVDA

185.56

+0.26%↑

AVGO.US

356.61

+1.8%↑

ORCL

202.03

-1.54%↓

MU

341.18

-1.13%↓

CSCO

74.74

+1.45%↑

NVDA

185.56

+0.26%↑

AVGO.US

356.61

+1.8%↑

ORCL

202.03

-1.54%↓

MU

341.18

-1.13%↓

CSCO

74.74

+1.45%↑

Search

Azenta Inc

Aperta

SettoreSettore delle tecnologie

37.96 1.93

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

37.01

Massimo

38.18

Metriche Chiave

By Trading Economics

Entrata

50M

51M

Vendite

15M

159M

P/E

Media del settore

67.453

73.655

Margine di Profitto

31.944

Dipendenti

3,000

EBITDA

2.7M

21M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+11.55% upside

Dividendi

By Dow Jones

Utili prossimi

4 feb 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

298M

1.6B

Apertura precedente

36.03

Chiusura precedente

37.96

Notizie sul Sentiment di mercato

By Acuity

50%

50%

166 / 403 Classifica in Technology

Azenta Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

12 gen 2026, 23:54 UTC

Discorsi di Mercato

CBA Could Underperform Again in 2026 -- Market Talk

12 gen 2026, 23:48 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

12 gen 2026, 23:48 UTC

Discorsi di Mercato

Nikkei May Rise on Weaker Yen -- Market Talk

12 gen 2026, 23:43 UTC

Discorsi di Mercato

Gold Edges Lower on Likely Technical Correction -- Market Talk

12 gen 2026, 23:18 UTC

Acquisizioni, Fusioni, Takeovers

Paramount Sues Warner Bros., Plans Proxy Fight. The Ellisons Aren't Giving Up. -- Barrons.com

12 gen 2026, 21:56 UTC

Discorsi di Mercato

Light & Wonder Gets Positive Outcome From Lawsuit -- Market Talk

12 gen 2026, 21:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

12 gen 2026, 21:50 UTC

Discorsi di Mercato

Health Care Roundup: Market Talk

12 gen 2026, 21:50 UTC

Discorsi di Mercato
Utili

Auto & Transport Roundup: Market Talk

12 gen 2026, 21:18 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

12 gen 2026, 21:18 UTC

Discorsi di Mercato

Pfizer CEO Sees Large Cash Market for Obesity Drugs -- Market Talk

12 gen 2026, 20:54 UTC

Utili

Gap, Fortinet, and More Stocks That Usually Outperform After Earnings -- Barrons.com

12 gen 2026, 20:48 UTC

Discorsi di Mercato

Oil Futures Settle Higher in Choppy Trade -- Market Talk

12 gen 2026, 20:33 UTC

Discorsi di Mercato

U.S. Natural Gas Jumps on Colder Weather Outlook -- Market Talk

12 gen 2026, 20:18 UTC

Acquisizioni, Fusioni, Takeovers

Credit Agricole Sees Banco BPM Stake Helping 2025 Net by EUR200M >ACA.FR

12 gen 2026, 20:18 UTC

Acquisizioni, Fusioni, Takeovers

Credit Agricole: European Central Bank Approves Crossing of 20% Threshold in Share Capital of Banco BPM

12 gen 2026, 19:39 UTC

Discorsi di Mercato

J&J CEO: Trump Pact Allows Company to Focus on Core Operations -- Market Talk

12 gen 2026, 19:36 UTC

Discorsi di Mercato

Gold and Silver Set New Records on Fed Probe -- Market Talk

12 gen 2026, 19:36 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

12 gen 2026, 19:33 UTC

Discorsi di Mercato

Venezuela's 'Proven' Oil Reserves Raises Questions -- Market Talk

12 gen 2026, 19:24 UTC

Acquisizioni, Fusioni, Takeovers

Dynavax: 'Party A' CEO Sent a Non-Binding $15/Shr Proposal on Dec. 23

12 gen 2026, 19:22 UTC

Acquisizioni, Fusioni, Takeovers

Dynavax Files Tender Offer Recommendation Statement Related to Sanofi Deal, Mentions Talks With 'Party A'

12 gen 2026, 18:21 UTC

Acquisizioni, Fusioni, Takeovers

Paramount Plans Proxy Fight to Push Hostile Warner Bid -- 2nd Update

12 gen 2026, 18:20 UTC

Acquisizioni, Fusioni, Takeovers

This French Biotech Stock Surged 1,700% in 2025. Eli Lilly Is Taking an Interest. -- Barrons.com

12 gen 2026, 18:19 UTC

Discorsi di Mercato

Modest Canadian Economic Impact Seen from Venezuela Changes -- Market Talk

12 gen 2026, 18:16 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Comcast Could Unlock Value With a Spinoff of NBCUniversal Assets, Analysts Say -- Market Talk

12 gen 2026, 18:09 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

12 gen 2026, 18:09 UTC

Discorsi di Mercato

Baidu's Outlook Bodes Well For Shares -- Market Talk

12 gen 2026, 18:01 UTC

Acquisizioni, Fusioni, Takeovers

QXO Is Raising Another $1.8 Billion for Its M&A War Chest -- Barrons.com

12 gen 2026, 18:00 UTC

Discorsi di Mercato

Canada's 'Breakeven' Employment Recalibrating -- Market Talk

Confronto tra pari

Modifica del prezzo

Azenta Inc Previsione

Obiettivo di Prezzo

By TipRanks

11.55% in crescita

Previsioni per 12 mesi

Media 41.83 USD  11.55%

Alto 50 USD

Basso 31 USD

Basato su 6 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Azenta Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

6 ratings

5

Acquista

1

Mantieni

0

Vendi

Sentiment

By Acuity

166 / 403 Classifica in Settore delle tecnologie

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Azenta Inc

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates through three reportable segments: Sample Management Solutions, Multiomics, and B Medical Systems. The Sample Management Solutions segment provides sample management products and solutions, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services. This segment also offers consultation services to clients throughout their experimental design and implementation processes. The Multiomics segment provides genomic and other sample analysis services comprising gene sequencing, synthesis editing, and related services. The B Medical Systems segment manufactures and distributes temperature-controlled storage and transportation solutions to governments, health institutions, and non-government organizations. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.
help-icon Live chat